Current concepts in the diagnosis and treatment of recurrent authors stomatitis- A systematic review
Background- Recurrent aphthous stomatitis (RAS) is a very common condition characterized by recurrent painful oral ulcers, which significantly affect the quality of life in affected patients. Despite its high prevalence, the etiology and optimal management of RAS remain elusive. A variety of therapeutic interventions, from topical and systemic treatments to newer approaches such as laser therapy, probiotics, and plant-based therapies, have been pursued. Objective: This systematic review aims to analyze the published evidence on the diagnosis and treatment of RAS, in terms of discovering effective interventions and gaps in the literature. Methods- RCTs on diagnosis or treatment of RAS were included. A systematic search was conducted across six databases: PubMed, Scopus, Embase, Web of Science, Cochrane Library, and CINAHL, employing Boolean operators and MeSH terms. Data were independently extracted by two reviewers; these included study characteristics, population demographics, interventions, outcomes, and statistical methods. The risk of bias was assessed employing the Cochrane Risk of Bias 2.0 tool. Results- A total of ten RCTs was included, ranging between diverse interventions such as probiotics, laser therapy, systemic drugs, and plant-based therapies. Commonly analyzed main outcomes included pain reduction as well as ulcer size, while some studies of healing time, recurrence rates, and complete remission took place. Pain and ulcer size reduced the most significantly in laser therapy, probiotics, and topical agents like zinc sulfate and caffeic acid. Vitamin B12 significantly decreased recurrence rates and reached a high ulcer-free status. Multivitamin supplementation was devoid of significant effects. The vast majority of studies reported no adverse events; however, systemic drugs such as thalidomide and dapsone were accompanied by well-known toxicities. Statistically, the methods utilized were Mann-Whitney U, Friedman tests, and advanced models such as ANCOVA in order to strengthen the analysis. Conclusion- This review demonstrated that advanced treatments, including laser therapy, probiotics, and natural compounds, are effective for the treatment of RAS, so promising alternatives emerge for currently used methods. Systemic drugs still prevail in extreme cases but are limited by side effects. The results highlight the imperatives of personalized therapeutic strategies and high-quality research to promote optimization in the management of RAS